📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
62
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛅
Watch
Minor dilution signals detected
19%
🔄 Reverse Split
30%
• 50-day avg $1.70 approaching $1 threshold
📉 Score Deterioration
15%
• Score climbed 5 points (worsening)
💹 Market Data
Market Cap$1.22M
Shares Outstanding1.02M
Float263.3K
Cash$5.21M
Debt$3.08M
Short InterestN/A
🏛 Institutional Holdings
1 institutional holders · 861 shares
#1
UBS Group AG
861 shares
📉 Short Interest
Short Interest10.0K
Days to Cover1.0
% of Float3.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for PAVS
📊 PAVS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 PAVS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.